Active

MEDITHERA

Switched

BE0429134433

Rechtspersoon Public limited company 1 establishment

Avenue de Merode 36, 1330 Rixensart Detailhandel in farmaceutische producten

Active for

40 year, 2 months

Financials

Financial year 2025

Worth noting

  • The team shrank two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ 375,156

▲ 24% vs 2024

Profit

Growing

€ 11,471

▲ 114% vs 2024

Debts

Low

€ 572,968

▼ 10% vs 2024

MEDITHERA from Rixensart, company number BE0429134433, closed financial year 2025 with a result of € 11,471 after tax. For that financial year MEDITHERA recorded a gross margin of € 375,156 and equity of € 399,044. Compared with financial year 2024, the result moved from € -82,311 to € 11,471. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What happened at MEDITHERA?

What happened at MEDITHERA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 11,471. Source: NBB ↗
  • New establishment in Rixensart. KBO
  • Start of the company according to the CBE. KBO

In short

From € 22,053 loss in 2021 to € 11,471 profit in 2025.

Paid € 29,180 in corporate taxes since 2021.

Best year ever: 2022, with € 55,403 profit.

On average € 69,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at MEDITHERA? We notify you, reason included.

Follow MEDITHERA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

MARC SEUTIN
PATRICIA BONABOT
MEDITHERA
DEFRANCE PHARMACIE 100%

Behind MEDITHERA are MARC SEUTIN and PATRICIA BONABOT. It owns 100% of DEFRANCE PHARMACIE itself.

See the full network in the app

Directors

According to the 2025 annual accounts

MARC SEUTIN

Director

PATRICIA BONABOT

Managing director

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue de Merode 36

1330 Rixensart

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0429.134.433
VAT number
BE 0429.134.433
Registered office
Avenue de Merode 36, 1330 Rixensart
Names & denominations
MEDITHERA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
30 June 1986
Peppol
Active · Active since 7 Nov 2025
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of MEDITHERA?
The enterprise number of MEDITHERA is BE0429134433.
What is the address of MEDITHERA?
The registered office of MEDITHERA is located at Avenue de Merode 36, 1330 Rixensart.
When was MEDITHERA founded?
MEDITHERA was founded on 30 June 1986.
What is the main activity of MEDITHERA?
The main activity of MEDITHERA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does MEDITHERA have a website?
No website is currently known for MEDITHERA.
How much profit did MEDITHERA make in 2025?
MEDITHERA posted a profit after taxes of € 11,471 in financial year 2025.
What is the revenue of MEDITHERA?
As a small company, MEDITHERA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 375,156.
How many employees does MEDITHERA have?
According to the 2025 annual accounts, MEDITHERA has 5.4 full-time equivalents (FTE).
Where can I find the annual accounts of MEDITHERA?
MEDITHERA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of MEDITHERA?
According to the 2025 annual accounts, the directors of MEDITHERA are: MARC SEUTIN, PATRICIA BONABOT.
Who owns MEDITHERA?
Behind MEDITHERA are MARC SEUTIN and PATRICIA BONABOT. It owns 100% of DEFRANCE PHARMACIE itself.